Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
Total Revenue | 2,495,322 | 4,142,862 | 6,433,363 | 5,812,255 |
Cost of Revenue | 1,837,543 | 484,218 | 5,100,698 | 4,344,512 |
Gross Profit | 657,779 | 803,116 | 1,332,665 | 1,467,743 |
Operating Expenses | ||||
Research Development | 361,812 | 74,976 | 538,009 | 430,822 |
Selling General and Administrative | 503,071 | 100,945 | 620,460 | 430,437 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 0 | 0 | 0 |
Total Operating Expenses | 864,883 | 175,921 | 1,158,469 | 861,259 |
Operating Income or Loss | (207,104) | 3,482,723 | 174,196 | 606,484 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (6,750) | (14,504) | 45,295 | 12,408 |
Earnings Before Interest And Taxes | (228,404) | (364,269) | 174,196 | 606,484 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (228,404) | (372,533) | 265,609 | 652,370 |
Income Tax Expense | (15,822) | (65,875) | 31,154 | 77,887 |
Minority Interest | 11,934 | 12,399 | -- | (3,162) |
Net Income From Continuing Ops | (212,582) | (288,308) | 229,706 | 573,371 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 465 | 0 | (953) | 1,825 |
Net Income | (212,117) | (288,308) | 228,753 | 575,196 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | (212,117) | 3,556,726 | 228,753 | 572,746 |